- Home
- NMS vs RENB Comparison
NMS vs RENB Comparison
Compare NMS & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMS
- RENB
- Stock Information
- Founded
- NMS 1993
- RENB 2011
- Country
- NMS United States
- RENB United States
- Employees
- NMS N/A
- RENB N/A
- Industry
- NMS Finance Companies
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- NMS Finance
- RENB Health Care
- Exchange
- NMS Nasdaq
- RENB Nasdaq
- Market Cap
- NMS 68.7M
- RENB 62.0M
- IPO Year
- NMS N/A
- RENB N/A
- Fundamental
- Price
- NMS $11.36
- RENB $0.34
- Analyst Decision
- NMS
- RENB
- Analyst Count
- NMS 0
- RENB 0
- Target Price
- NMS N/A
- RENB N/A
- AVG Volume (30 Days)
- NMS 12.0K
- RENB 7.5M
- Earning Date
- NMS 01-01-0001
- RENB 05-15-2025
- Dividend Yield
- NMS 4.11%
- RENB N/A
- EPS Growth
- NMS N/A
- RENB N/A
- EPS
- NMS N/A
- RENB N/A
- Revenue
- NMS N/A
- RENB N/A
- Revenue This Year
- NMS N/A
- RENB N/A
- Revenue Next Year
- NMS N/A
- RENB N/A
- P/E Ratio
- NMS N/A
- RENB N/A
- Revenue Growth
- NMS N/A
- RENB N/A
- 52 Week Low
- NMS $9.21
- RENB $0.27
- 52 Week High
- NMS $12.18
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- NMS 45.28
- RENB 49.44
- Support Level
- NMS $11.31
- RENB $0.32
- Resistance Level
- NMS $11.49
- RENB $0.40
- Average True Range (ATR)
- NMS 0.09
- RENB 0.06
- MACD
- NMS 0.01
- RENB 0.01
- Stochastic Oscillator
- NMS 50.00
- RENB 39.67
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.